$298,000
$330,000
a year
... a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for ... our mid-to late-stage clinical trials to bring new potential ...
2 days ago
$228,000
$255,000
a year
... a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for ... our mid-to late-stage clinical trials to bring new potential ...
2 days ago